{"DataElement":{"publicId":"5647608","version":"3","preferredName":"Germ Cell Tumor Histologic Classification Type","preferredDefinition":"Information as to the histological classification type of a germ cell tumor.","longName":"GCT_HSCL_TY","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"2191293","version":"1","preferredName":"Germ Cell Tumor Histologic Classification","preferredDefinition":"information related to histologic classification of a germ cell tumor.","longName":"GERM_TUM_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2660462","version":"1","preferredName":"Germ Cell Neoplasm","preferredDefinition":"A reproductive cell of the body. Germ cells are egg cells in females and sperm cells in males.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12597:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell","conceptCode":"C12597","definition":"Gametes, also known as sex cells or germ cells, are the cells that come together during fertilization or conception in organisms that reproduce sexually.  Their genetic complement consists of a single set of unpaired chromosomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E5C497-ECC0-4C81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E86201D2-3230-3C4F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5647599","version":"1.1","preferredName":"Germ Cell Tumor Histologic Classification Type","preferredDefinition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._Something distinguishable as an identifiable class based on common qualities.","longName":"5647599v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yolk sac tumor","valueDescription":"Yolk Sac Tumor","ValueMeaning":{"publicId":"4264851","version":"1","preferredName":"Yolk Sac Tumor","longName":"4264851","preferredDefinition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells.  It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yolk Sac Tumor","conceptCode":"C3011","definition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells.  It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42F0-0203-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8025B368-B915-3A4C-E053-F662850A4228","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","deletedIndicator":"No"},{"value":"Seminoma","valueDescription":"Seminoma","ValueMeaning":{"publicId":"2575033","version":"1","preferredName":"Seminoma","longName":"2575033","preferredDefinition":"A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seminoma","conceptCode":"C9309","definition":"A radiosensitive malignant germ cell tumor found in the testis (especially undescended), and extragonadal sites (anterior mediastinum and pineal gland).  It is characterized by the presence of uniform cells with clear or dense cytoplasm which contains glycogen, and by a large nucleus which contains one or more nucleoli.  The neoplastic germ cells form aggregates separated by fibrous septa.  The fibrous septa contain chronic inflammatory cells, mainly lymphocytes.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F226-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-23","modifiedBy":"COOPERM","dateModified":"2016-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8025B368-B91F-3A4C-E053-F662850A4228","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","deletedIndicator":"No"},{"value":"Dysgerminoma","valueDescription":"Dysgerminoma","ValueMeaning":{"publicId":"2574078","version":"1","preferredName":"Dysgerminoma","longName":"2574078","preferredDefinition":"Dysgerminoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysgerminoma","conceptCode":"C2996","definition":"A malignant germ cell tumor characterized by the presence of a monotonous primitive germ cell population.  The neoplastic cells form aggregates and have an abundant pale cytoplasm and uniform nuclei.  The aggregates of the germ cells are separated by fibrous septa which contain inflammatory cells, mostly T-lymphocytes.  It arises primarily in the ovaries, but can occur both primarily and secondarily at other sites, particularly the central nervous system.  It responds to chemotherapy and radiotherapy. Its prognosis is related to the tumor stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8025B368-B929-3A4C-E053-F662850A4228","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","deletedIndicator":"No"},{"value":"Embryonal carcinoma","valueDescription":"Embryonal carcinoma","ValueMeaning":{"publicId":"2567194","version":"1","preferredName":"Embryonal carcinoma","longName":"2567194","preferredDefinition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Carcinoma","conceptCode":"C3752","definition":"A non-seminomatous malignant germ cell tumor characterized by the presence of large germ cells with abundant cytoplasm resembling epithelial cells, geographic necrosis, high mitotic activity, and pseudoglandular and pseudopapillary structures formation. It can arise from the testis, ovary, and extragonadal sites (central nervous system and mediastinum).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D387-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Added missing system generated definition. mc 11/9/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8025B368-B933-3A4C-E053-F662850A4228","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","deletedIndicator":"No"},{"value":"Choriocarcinoma","valueDescription":"Choriocarcinoma","ValueMeaning":{"publicId":"2837860","version":"1","preferredName":"Choriocarcinoma","longName":"2837860","preferredDefinition":"An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choriocarcinoma","conceptCode":"C2948","definition":"An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-491B-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8025B368-B93D-3A4C-E053-F662850A4228","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","deletedIndicator":"No"},{"value":"Teratoma immature","valueDescription":"Immature Teratoma","ValueMeaning":{"publicId":"2838862","version":"1","preferredName":"Immature Teratoma","longName":"2838862","preferredDefinition":"A teratoma composed of immature, fetal-type tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immature Teratoma","conceptCode":"C4286","definition":"A teratoma characterized by the presence of an extensive component of immature, fetal-type tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A98887-3AC1-9A11-E040-BB89AD434E3A","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8025B368-B947-3A4C-E053-F662850A4228","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","deletedIndicator":"No"},{"value":"Teratoma mature","valueDescription":"Mature Teratoma","ValueMeaning":{"publicId":"2838857","version":"1","preferredName":"Mature Teratoma","longName":"2838857","preferredDefinition":"A teratoma which may be cystic; it is composed entirely of well differentiated, adult-type tissues, without evidence of fetal-type tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mature Teratoma","conceptCode":"C9015","definition":"A teratoma which may be cystic; it is composed entirely of well differentiated, adult-type mature tissues, without evidence of fetal-type immature tissues (grade 0 teratoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A98887-3A3C-9A11-E040-BB89AD434E3A","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8025B368-B951-3A4C-E053-F662850A4228","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","deletedIndicator":"No"},{"value":"Non Viable Tissue","valueDescription":null,"ValueMeaning":{"publicId":"7590843","version":"1","preferredName":"Unusable Tissue","longName":"7590843","preferredDefinition":"Not fit for the intended purpose.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unusable","conceptCode":"C126376","definition":"Not fit for the intended purpose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCD0E3C4-D944-2ABD-E053-4EBD850A3159","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"ONEDATA","dateModified":"2021-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4334C49-DD91-7624-E053-731AD00A6E9F","beginDate":"2023-02-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-02-08","modifiedBy":"KUMMEROA","dateModified":"2023-02-08","deletedIndicator":"No"},{"value":"Germ Cell Tumor, NOS","valueDescription":null,"ValueMeaning":{"publicId":"7590844","version":"1","preferredName":"Germ Cell Tumor Unspecified","longName":"7590844","preferredDefinition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.: Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell Tumor","conceptCode":"C3708","definition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCD0E3C4-D96C-2ABD-E053-4EBD850A3159","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"ONEDATA","dateModified":"2021-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4334C49-DD92-7624-E053-731AD00A6E9F","beginDate":"2023-02-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-02-08","modifiedBy":"KUMMEROA","dateModified":"2023-02-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6618371","version":"1","preferredName":"Germ Cell Tumor Histologic Classification Type","preferredDefinition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.:Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3708:C25526:C25161:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell Tumor","conceptCode":"C3708","definition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"802249BE-F166-72C6-E053-F662850AE7E9","latestVersionIndicator":"Yes","beginDate":"2019-01-23","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"ONEDATA","dateModified":"2019-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8025B368-B8FF-3A4C-E053-F662850A4228","latestVersionIndicator":"Yes","beginDate":"2017-02-01","endDate":null,"createdBy":"GALITG","dateCreated":"2019-01-23","modifiedBy":"KUMMEROA","dateModified":"2023-02-08","changeDescription":"10.16.20 TL moved from RETIRED WITHDRAWN to RETIRED ARCHIVED and added End Date in preparation of MDR.; Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 Reverted to Retired Withdrawn  G. Galit 01.23.2019","administrativeNotes":"2023.2.8 Took out of retirement due to v1 in use as well. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the histological classification type of the germ cell tumor?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Pathology Result:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Germ cell tumor histology:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F43353FB-7BBA-76EA-E053-731AD00A2698","latestVersionIndicator":"Yes","beginDate":"2021-03-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-02-08","modifiedBy":"KUMMEROA","dateModified":"2023-02-08","changeDescription":"6/14/18 - Retired CDEs in order to curate new bsm. 05.16.18 Reverted to Retired Withdrawn.G Galit 01.23.2019. Unretired by LS on 3/11/21","administrativeNotes":"2023.2.8 Created new version to reflect versioned VD that was created. ak","unresolvedIssues":null,"deletedIndicator":"No"}}